🔎 Trials Near Me

Home › Prostate Cancer › Texas › The Woodlands

Prostate Cancer clinical trials in The Woodlands, TX

6 studies for Prostate Cancer are looking for participants at sites in and around The Woodlands (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

RecruitingPhase 3
  • Woodlands Cancer Institute American Oncology Partners, The Woodlands
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

RecruitingPhase 3
  • Research Site, Spring · 7 mi away
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06952803

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RecruitingPhase 3
  • MD Anderson in The Woodlands, Conroe · 11 mi away
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

RecruitingPhase 3
  • Houston Methodist The Woodlands Hospital, The Woodlands
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

RecruitingPhase 3
  • MD Anderson in The Woodlands, Conroe · 11 mi away
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in The Woodlands

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.